Breaking News Instant updates and real-time market news.

TXT

Textron

$65.07

-0.015 (-0.02%)

, BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

08:09
10/15/18
10/15
08:09
10/15/18
08:09

Textron Aviation, NetJets announce agreements for option to expand fleet

Textron Aviation, a Textron (TXT) company, and NetJets, a Berkshire Hathaway (BRK.A, BRK.B) company, announced fleet agreements for the option to purchase up to 175 super-midsize Cessna Citation Longitude aircraft and up to 150 Cessna Citation Hemisphere aircraft. NetJets has operated a fleet of nearly 500 Cessna Citations since 1984, and this agreement could increase the fleet to more than 800 aircraft over the next 10 to 15 years. The option to purchase the Hemisphere distinguishes NetJets as the launch customer for Textron Aviation's revolutionary, clean sheet large-cabin aircraft. With an enduring relationship of more than 30 years, Textron Aviation and NetJets equip discerning customers with class-leading, safe and reliable aviation travel experiences worldwide. Beginning with the industry-defining Citation SII, NetJets has owned and operated nearly 500 Citation aircraft, including the Citation Latitude, Sovereign, Excel/XLS and X. NetJets has the option to take first deliveries of the Citation Longitude in the second half of 2019, with additional options on Longitude aircraft exercised over the following 10 to 15 years. Textron Aviation and NetJets are designing a version of the clean sheet Citation Hemisphere to meet the discerning standards of NetJets Owners. This side-by-side collaboration enables NetJets and Textron to join together to create a world-class aviation experience for NetJets Owners. They are also working with Safran to achieve performance characteristics that enable Hemisphere to reach far off destinations with greater speed and reliability. To date, NetJets operates a fleet of 75 Citation Latitudes and expects to have 100 in service by mid-2019.

TXT

Textron

$65.07

-0.015 (-0.02%)

BRK.A

Berkshire Hathaway

$310,740.00

2727.91 (0.89%)

BRK.B

Berkshire Hathaway

$206.72

1.41 (0.69%)

  • 18

    Oct

TXT Textron
$65.07

-0.015 (-0.02%)

09/26/18
JEFF
09/26/18
NO CHANGE
Target $82
JEFF
Buy
Textron price target raised to $82 from $77 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for Textron to $82 after meeting with CEO Scott Donnelly and CFO Frank Connor. The analyst is "incrementally more positive" on demand in the business jet and commercial helicopter portfolios as well as on the company's product positioning. She keeps a Buy rating on Textron shares.
07/19/18
SBSH
07/19/18
NO CHANGE
Target $76
SBSH
Buy
Textron price target raised to $76 from $67 at Citi
Citi analyst Jonathan Raviv raised his price target for Textron to $76 citing an "improving earnings growth picture" following yesterday's Q2 results. Aviation's incremental margin outlook is "broadly positive" and Bell Commercial is stabilizing, Raviv tells investors in a post-earnings research note. He remains a buyer of Textron shares and keeps a Buy rating on the name.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
04/19/18
WELS
04/19/18
NO CHANGE
Target $72
WELS
Outperform
Textron price target raised to $72 from $67 at Wells Fargo
Wells Fargo analyst Sam Pearlstein raised his price target for Textron to $72 from $67 following quarterly results. The analyst reiterates an Outperform rating on the shares.
BRK.A Berkshire Hathaway
$310,740.00

2727.91 (0.89%)

08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/08/18
MSCO
08/08/18
NO CHANGE
Target $67
MSCO
Overweight
Southwest would be good strategic fit for Berkshire, says Morgan Stanley
Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan, who said he has no knowledge of any M&A discussions and noted that the airlines have not commented. Given that background, he analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation, in which he also thinks Berkshire would divest its current holdings in American Airlines (AAL), Delta (DAL) and United Continental (UAL). Pan has an Overweight rating and $67 price target on Southwest shares.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
09/19/18
GDHS
09/19/18
NO CHANGE
GDHS
AutoNation doesn't profile as very good sale candidate, says Gordon Haskett
Gordon Haskett's Event-Driven researcher Don Bilson noted that Berkshire Hathaway's (BRK.A) Warren Buffett previously stated with his purchase of Van Tuyl Group that "this is the beginning of a journey that will have no end." While Berkshire buying AutoNation (AN) would "certainly obviate the need for [Chairman and CEO Mike] Jackson to continue on with his search" for a successor, Bilson said AutoNation "doesn't profile as a very good sale candidate" and "this doesn't set up as a situation where Jackson might sell the company as part of his exit."
BRK.B Berkshire Hathaway
$206.72

1.41 (0.69%)

07/18/18
MSCO
07/18/18
NO CHANGE
MSCO
Equal Weight
Berkshire amendment signals interest in buying back shares, says Morgan Stanley
After Berkshire Hathaway's board authorized an amendment to the company's share repurchase program, Morgan Stanley analyst Kai Pan noted that Warren Buffett has indicated that the gap between Berkshire's intrinsic value and book value is widening and Pan thinks the amendment signals the company's interest in buying back its own shares. However, Berkshire will not initiate any buybacks until it releases Q2 earnings after market close on Friday, August 3, the analyst notes. Pan, who thinks "solid" Q2 results and buybacks should be positive catalysts, keeps an Equal Weight rating on Berkshire shares.
06/21/18
BERN
06/21/18
NO CHANGE
BERN
Amazon/JPMorgan/Berkshire venture still negative for drug supply chain, says Bernstein
Bernstein analyst Lance Wilkes notes that Amazon (AMZN), Berkshire Hathaway (BRK.A; BRK.B) and JPMorgan (JPM) announced the appointment of Atul Gawande as the CEO of their new healthcare joint venture, effective July 9th. The analyst sees this appointment as indicating an emphasis on enablement of change in the system, along with thought and policy leadership, and believes the appointment of an operating oriented President or COO could refine the outlook for scope. Wilkes continues to see this venture as negative for drug supply chain and self-insured employer oriented MCOs.

TODAY'S FREE FLY STORIES

WIT

Wipro

$3.76

0.07 (1.90%)

09:57
10/15/19
10/15
09:57
10/15/19
09:57
Earnings
Wipro reports Q2 EPS 6c, consensus 6c »

Reports Q2 revenue $2.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

UNH

UnitedHealth

$233.50

13.18 (5.98%)

, ANTM

Anthem

$244.77

10.04 (4.28%)

09:55
10/15/19
10/15
09:55
10/15/19
09:55
Options
Early notable gainers among liquid option names on October 15th »

Notable gainers among…

UNH

UnitedHealth

$233.50

13.18 (5.98%)

ANTM

Anthem

$244.77

10.04 (4.28%)

CI

Cigna

$157.49

5.875 (3.87%)

SCHW

Charles Schwab

$38.63

0.89 (2.36%)

NVDA

Nvidia

$192.32

5.81 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 31

    Oct

  • 20

    Nov

EMR

Emerson

$66.89

-0.32 (-0.48%)

09:54
10/15/19
10/15
09:54
10/15/19
09:54
Hot Stocks
D. E. Shaw sees 50% upside in Emerson shares, calls for cost cuts and split »

D. E. Shaw Group, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

JNJ

Johnson & Johnson

$132.66

1.99 (1.52%)

09:53
10/15/19
10/15
09:53
10/15/19
09:53
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

EMR

Emerson

$67.03

-0.18 (-0.27%)

09:51
10/15/19
10/15
09:51
10/15/19
09:51
Hot Stocks
Breaking Hot Stocks news story on Emerson »

D.E. Shaw calls for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

TNDM

TNDM

, ABT

Abbott

$81.63

1.82 (2.28%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
TNDM, Abbott, DexCom, Insulet analyst commentary  »

Abbott partnership a…

TNDM

TNDM

ABT

Abbott

$81.63

1.82 (2.28%)

DXCM

DexCom

$153.56

-6.64 (-4.14%)

PODD

Insulet

$154.02

1.72 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

AMBA

Ambarella

$56.30

3.19 (6.01%)

09:50
10/15/19
10/15
09:50
10/15/19
09:50
Recommendations
Ambarella analyst commentary  »

KeyBanc boosts Ambarella…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

09:50
10/15/19
10/15
09:50
10/15/19
09:50
General news
IMF's global growth outlooks were trimmed »

IMF's global growth…

NR

Newpark Resources

$6.77

-0.155 (-2.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Newpark Resources falls -5.3% »

Newpark Resources is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

MTW

Manitowoc

$10.71

-0.68 (-5.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Manitowoc falls -5.9% »

Manitowoc is down -5.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$40.25

-6 (-12.97%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
PagSeguro Digital falls -13.7% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

  • 17

    Oct

UNH

UnitedHealth

$233.30

12.98 (5.89%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
UnitedHealth rises 5.7% »

UnitedHealth is up 5.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

FRC

First Republic

$103.44

6.08 (6.24%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
First Republic rises 6.0% »

First Republic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

APHA

Aphria

$5.39

1.06 (24.48%)

09:47
10/15/19
10/15
09:47
10/15/19
09:47
Hot Stocks
Aphria rises 21.8% »

Aphria is up 21.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

TBPH

Theravance Biopharma

$17.25

(0.00%)

09:45
10/15/19
10/15
09:45
10/15/19
09:45
Syndicate
Theravance Biopharma 5.7M share Block Trade priced at $17.50 »

Woodford Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYSI

BeyondSpring

$18.08

(0.00%)

09:44
10/15/19
10/15
09:44
10/15/19
09:44
Syndicate
Breaking Syndicate news story on BeyondSpring »

BeyondSpring files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

EMR

Emerson

$67.21

(0.00%)

09:43
10/15/19
10/15
09:43
10/15/19
09:43
Periodicals
D.E. Shaw report calling for Emerson split coming today, CNBC reports »

D.E. Shaw has over a 1%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

STLD

Steel Dynamics

$29.64

(0.00%)

, IGT

International Game

$14.02

(0.00%)

09:40
10/15/19
10/15
09:40
10/15/19
09:40
Options
Unusually active option classes on open October 15th »

Unusual total active…

STLD

Steel Dynamics

$29.64

(0.00%)

IGT

International Game

$14.02

(0.00%)

JPM

JPMorgan

$116.39

(0.00%)

UNH

UnitedHealth

$220.32

(0.00%)

GS

Goldman Sachs

$205.81

(0.00%)

NVDA

Nvidia

$186.51

(0.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.83

(0.00%)

C

Citi

$70.28

(0.00%)

WLL

Whiting Petroleum

$7.26

(0.00%)

SCHW

Charles Schwab

$37.74

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 17

    Oct

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 06

    Nov

  • 12

    Nov

  • 20

    Nov

CPIX

Cumberland

$5.59

-0.05 (-0.89%)

09:38
10/15/19
10/15
09:38
10/15/19
09:38
Hot Stocks
Cumberland: Study shows Vibativ superiority in some bacterial pneumonia patients »

Cumberland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$67.21

0.16 (0.24%)

09:37
10/15/19
10/15
09:37
10/15/19
09:37
Periodicals
Breaking Periodicals news story on Emerson »

D.E. Shaw to call for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

IAC

IAC

$226.69

-0.5 (-0.22%)

, MTCH

Match Group

$74.00

-0.12 (-0.16%)

09:34
10/15/19
10/15
09:34
10/15/19
09:34
Conference/Events
Cowen US internet/media analyst to hold analyst/industry conference call »

U.S. Internet & Media…

IAC

IAC

$226.69

-0.5 (-0.22%)

MTCH

Match Group

$74.00

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.28

-0.14 (-3.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

WLL

Whiting Petroleum

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

OAS

Oasis Petroleum

$3.11

-0.135 (-4.17%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$20.44

-0.15 (-0.73%)

09:31
10/15/19
10/15
09:31
10/15/19
09:31
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.